7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Dentin Dysplasia D003805 1 associated lipids
Neoplasms, Squamous Cell D018307 1 associated lipids
Osteoporotic Fractures D058866 1 associated lipids
Hemangioma, Capillary D018324 1 associated lipids
Prediabetic State D011236 1 associated lipids
Cleidocranial Dysplasia D002973 1 associated lipids
Scleroderma, Limited D045745 1 associated lipids
Rheumatic Fever D012213 1 associated lipids
Chronic Periodontitis D055113 1 associated lipids
Intracranial Hemorrhage, Traumatic D020198 1 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Wang ST et al. Increased plasma osteoprotegerin concentrations in Type 1 diabetes with albuminuria. 2013 Clin. Nephrol. pmid:23073066
Honma M et al. RANKL subcellular trafficking and regulatory mechanisms in osteocytes. 2013 J. Bone Miner. Res. pmid:23529793
Vinholt PJ et al. An ELISA for the quantitation of von Willebrand factor: osteoprotegerin complexes in plasma. 2013 Thromb. Res. pmid:23531238
Shang M et al. Association of genetic polymorphisms of RANK, RANKL and OPG with bone mineral density in Chinese peri- and postmenopausal women. 2013 Clin. Biochem. pmid:23531404
Jin J et al. Risedronate inhibits bone marrow mesenchymal stem cell adipogenesis and switches RANKL/OPG ratio to impair osteoclast differentiation. 2013 J. Surg. Res. pmid:22487394
Zhan X et al. Storage media enhance osteoclastogenic potential of human periodontal ligament cells via RANKL-independent signaling. 2013 Dent Traumatol pmid:22487464
Luo J et al. 1,25-dihydroxyvitamin D3 inhibits the RANKL pathway and impacts on the production of pathway-associated cytokines in early rheumatoid arthritis. 2013 Biomed Res Int pmid:23710436
Neunaber C et al. Differentiation of osteoprogenitor cells is affected by trauma-haemorrhage. 2013 Injury pmid:23773407
Kadow-Romacker A et al. Effect of β-tricalcium phosphate coated with zoledronic acid on human osteoblasts and human osteoclasts in vitro. 2013 J Biomater Appl pmid:21862509
Hakimi M et al. The expression of glycophorin A and osteoprotegerin is locally increased in carotid atherosclerotic lesions of symptomatic compared to asymptomatic patients. 2013 Int. J. Mol. Med. pmid:23722820
Marshall AJ et al. Long-chain triazolyl acids as inhibitors of osteoclastogenesis. 2013 Bioorg. Med. Chem. pmid:23726411
Brzóska MM and Rogalska J Protective effect of zinc supplementation against cadmium-induced oxidative stress and the RANK/RANKL/OPG system imbalance in the bone tissue of rats. 2013 Toxicol. Appl. Pharmacol. pmid:23726800
Van Schepdael A et al. A mechanobiological model of orthodontic tooth movement. 2013 Biomech Model Mechanobiol pmid:22539046
Kim J et al. Plasma osteoprotegerin levels increase with the severity of cerebral artery atherosclerosis. 2013 Clin. Biochem. pmid:23726804
Saini V et al. Parathyroid hormone (PTH)/PTH-related peptide type 1 receptor (PPR) signaling in osteocytes regulates anabolic and catabolic skeletal responses to PTH. 2013 J. Biol. Chem. pmid:23729679
Wan S Editorial comment: The end of all our exploring ... 2013 Eur J Cardiothorac Surg pmid:23729753
Kim HR et al. The ratio of osteoprotegerin to fetuin-a is independently associated with vascular stiffness in hemodialysis patients. 2013 Nephron Clin Pract pmid:23921088
Steensma MR et al. Targeting the giant cell tumor stromal cell: functional characterization and a novel therapeutic strategy. 2013 PLoS ONE pmid:23922683
Czyzewska-Buczyńska A et al. [Assessment of osteopontin and osteoprotegerin levels in abdominal aortic aneurysm patients]. 2013 Prz. Lek. pmid:24003660
Fathilah SN et al. Labisia pumila regulates bone-related genes expressions in postmenopausal osteoporosis model. 2013 BMC Complement Altern Med pmid:24007208
Einvik G et al. Novel cardiovascular risk markers in depression: no association between depressive symptoms and osteoprotegerin or adiponectin in persons at high risk for sleep apnea. 2013 J Affect Disord pmid:22862888
Koufany M et al. The peroxisome proliferator-activated receptor γ agonist pioglitazone preserves bone microarchitecture in experimental arthritis by reducing the interleukin-17-dependent osteoclastogenic pathway. 2013 Arthritis Rheum. pmid:23982996
Mozzati M et al. Oral mucosa produces cytokines and factors influencing osteoclast activity and endothelial cell proliferation, in patients with osteonecrosis of jaw after treatment with zoledronic acid. 2013 Clin Oral Investig pmid:22864527
Ma XN et al. [Mechanisms of icariin in regulating bone formation of osteoblasts and bone resorption of osteoclasts]. 2013 Zhongguo Yi Xue Ke Xue Yuan Xue Bao pmid:23987492
Naumnik B et al. Age and gender predict OPG level and OPG/sRANKL ratio in maintenance hemodialysis patients. 2013 Adv Med Sci pmid:23959668
Belibasakis GN et al. The receptor activator of NF-κB ligand-osteoprotegerin system in pulpal and periapical disease. 2013 Int Endod J pmid:22900632
Kim SD et al. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice. 2013 Biochem. Pharmacol. pmid:23928189
Crosley LK et al. The single-nucleotide polymorphism (GPX4c718t) in the glutathione peroxidase 4 gene influences endothelial cell function: interaction with selenium and fatty acids. 2013 Mol Nutr Food Res pmid:23934705
Li F et al. Effect of parathyroid hormone on experimental tooth movement in rats. 2013 Am J Orthod Dentofacial Orthop pmid:24075660
Pneumaticos SG et al. Osteoprotegerin expression during the micro- and macrometastatic phases of the osteoblastic metastasis in prostate cancer: therapeutic implications. 2013 Expert Opin. Ther. Targets pmid:24024908
Matuszewski Ł et al. Effect of implanted bisphosphonate-enriched cement on the trabecular microarchitecture of bone in a rat model using micro-computed tomography. 2013 Int Orthop pmid:23503639
Tarantino U et al. A new antiresorptive approach to the treatment of fragility fractures: long-term efficacy and safety of denosumab. 2013 Aging Clin Exp Res pmid:24046047
Albers J et al. Canonical Wnt signaling inhibits osteoclastogenesis independent of osteoprotegerin. 2013 J. Cell Biol. pmid:23401003
Nahidi L et al. Osteoprotegerin exerts its pro-inflammatory effects through nuclear factor-κB activation. 2013 Dig. Dis. Sci. pmid:24048682
Hope S et al. Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder. 2013 Schizophr. Res. pmid:23403415
Thormann U et al. Bone formation induced by strontium modified calcium phosphate cement in critical-size metaphyseal fracture defects in ovariectomized rats. 2013 Biomaterials pmid:23906515
D'Amico L et al. Bone metastases in gastric cancer follow a RANKL-independent mechanism. 2013 Oncol. Rep. pmid:23404437
Lekesiz K et al. Effect of unfractionated heparin, enoxaparin and sulodexide on the relations between secretion and expression of OPG, RANKL and vWF in HUVEC. 2013 Folia Histochem. Cytobiol. pmid:23907946
Briana DD et al. Relationships between maternal novel adipocytokines and bone biomarkers in complicated by gestational hypertensive disorders and normal pregnancies. 2013 J. Matern. Fetal. Neonatal. Med. pmid:23406471
Enhos S et al. OPG and RANKL levels around miniscrew implants during orthodontic tooth movement. 2013 Am J Orthod Dentofacial Orthop pmid:23910201
McDonald MM et al. Matrix metalloproteinase-driven endochondral fracture union proceeds independently of osteoclast activity. 2013 J. Bone Miner. Res. pmid:23408642
Callegari A et al. Bone marrow- or vessel wall-derived osteoprotegerin is sufficient to reduce atherosclerotic lesion size and vascular calcification. 2013 Arterioscler. Thromb. Vasc. Biol. pmid:23990207
Oshita K et al. [Regulation of osteoclastogenesis by human mesenchymal stem cells leading to application of a novel treatment for rheumatoid arthritis]. 2013 J. UOEH pmid:23475022
Kress DC Invited commentary. 2013 Ann. Thorac. Surg. pmid:23992687
Mozzanega B et al. Cyclic variations of bone resorption mediators and markers in the different phases of the menstrual cycle. 2013 J. Bone Miner. Metab. pmid:23479185
Calderín S et al. Short-term clinical and osteoimmunological effects of scaling and root planing complemented by simple or repeated laser phototherapy in chronic periodontitis. 2013 Lasers Med Sci pmid:22546942
Yano S et al. Static and dynamic hypergravity responses of osteoblasts and osteoclasts in medaka scales. 2013 Zool. Sci. pmid:23480382
Ghaffari S et al. The value of serum osteoprotegerin levels in patients with angina like chest pain undergoing diagnostic coronary angiography. 2013 Cardiol J pmid:23788300
Wu M et al. Vascular calcification: an update on mechanisms and challenges in treatment. 2013 Calcif. Tissue Int. pmid:23456027
Venojärvi M et al. 12 weeks' aerobic and resistance training without dietary intervention did not influence oxidative stress but aerobic training decreased atherogenic index in middle-aged men with impaired glucose regulation. 2013 Food Chem. Toxicol. pmid:23623841
Kitamura K et al. Zebrafish scales respond differently to in vitro dynamic and static acceleration: analysis of interaction between osteoblasts and osteoclasts. 2013 Comp. Biochem. Physiol., Part A Mol. Integr. Physiol. pmid:23632157
Shen L et al. Association between osteoprotegerin genetic variants and bone mineral density in Chinese women. 2013 Int. Immunopharmacol. pmid:23619553
Xie GQ et al. Relationship between serum TGF-β1, OPG levels and osteoporotic risk in native Chinese women. 2013 Clin. Chim. Acta pmid:23643930
Aranha AM et al. Evidence supporting a protective role for th9 and th22 cytokines in human and experimental periapical lesions. 2013 J Endod pmid:23228262
Ding CZ et al. [Effects of zhengqing fengtongning tablet and methotrexate on the serum OPG/RANKL and IL-17 of collagen-induced arthritis rats]. 2013 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:23646485
Wang XF et al. The role of the serum RANKL/OPG ratio in the healing of intertrochanteric fractures in elderly patients. 2013 Mol Med Rep pmid:23440406
Jiang S et al. Changes of blood parameters associated with bone remodeling following experimentally induced fatty liver disorder in laying hens. 2013 Poult. Sci. pmid:23687138
Srivastava S et al. Assessment of the role of flavonoids for inducing osteoblast differentiation in isolated mouse bone marrow derived mesenchymal stem cells. 2013 Phytomedicine pmid:23570998
Fu YX et al. Influence of osteoprotegerin on differentiation, activation, and apoptosis of Gaoyou duck embryo osteoclasts in vitro. 2013 Poult. Sci. pmid:23687158
Zhong Z et al. Comparison of the biological response of osteoblasts after tension and compression. 2013 Eur J Orthod pmid:21402736
Lou Z et al. Smad3 is the key to transforming growth factor-β1-induced osteoclast differentiation in giant cell tumor of bone. 2013 Med. Oncol. pmid:23690270
Suliburska J et al. The association of insulin resistance with serum osteoprotegerin in obese adolescents. 2013 J. Physiol. Biochem. pmid:23695991
Kim J et al. Lipoproteins are an important bacterial component responsible for bone destruction through the induction of osteoclast differentiation and activation. 2013 J. Bone Miner. Res. pmid:23633269
Hussien YM et al. Polymorphism in vitamin D receptor and osteoprotegerin genes in Egyptian rheumatoid arthritis patients with and without osteoporosis. 2013 Mol. Biol. Rep. pmid:23271131
Tetè S et al. Maxillary sinus augmentation procedures through equine-derived biomaterial or calvaria autologous bone: immunohistochemical evaluation of OPG/RANKL in humans. 2013 Eur J Histochem pmid:23549459
Kuang B et al. Combined degenerative and regenerative remodeling responses of the mandibular condyle to experimentally induced disordered occlusion. 2013 Am J Orthod Dentofacial Orthop pmid:23273362
Matsuzaki E et al. Sphingosine-1-phosphate promotes the nuclear translocation of β-catenin and thereby induces osteoprotegerin gene expression in osteoblast-like cell lines. 2013 Bone pmid:23612487
Flórez-Moreno GA et al. Time-related changes in salivary levels of the osteotropic factors sRANKL and OPG through orthodontic tooth movement. 2013 Am J Orthod Dentofacial Orthop pmid:23273364
Brown TT et al. Body composition, soluble markers of inflammation, and bone mineral density in antiretroviral therapy-naive HIV-1-infected individuals. 2013 J. Acquir. Immune Defic. Syndr. pmid:23591634
Hyseni A et al. Chronic dysfunction of the endothelium is associated with mortality in acute coronary syndrome patients. 2013 Thromb. Res. pmid:23273402
Feng X et al. Modulatory effect of 1,25-dihydroxyvitamin D 3 on IL1 β -induced RANKL, OPG, TNF α , and IL-6 expression in human rheumatoid synoviocyte MH7A. 2013 Clin. Dev. Immunol. pmid:24348674
Engvall IL et al. Low-dose prednisolone in early rheumatoid arthritis inhibits collagen type I degradation by matrix metalloproteinases as assessed by serum 1CTP--a possible mechanism for specific inhibition of radiological destruction. 2013 Rheumatology (Oxford) pmid:23275387
Levidou G et al. TRAIL and osteoprotegerin (OPG) expression in bladder urothelial carcinoma: correlation with clinicopathological parameters and prognosis. 2013 Pathology pmid:23277172
de Moraes M et al. Immunoexpression of RANK, RANKL, OPG, VEGF, and vWF in radicular and dentigerous cysts. 2013 J. Oral Pathol. Med. pmid:23278112
Peris P et al. Effects of bisphosphonate treatment on circulating osteogenic endothelial progenitor cells in postmenopausal women. 2013 Mayo Clin. Proc. pmid:23228561
Zhang W et al. IL-18 upregulates the production of key regulators of osteoclastogenesis from fibroblast-like synoviocytes in rheumatoid arthritis. 2013 Inflammation pmid:22945280
Dieckmann M et al. Human apolipoprotein E isoforms differentially affect bone mass and turnover in vivo. 2013 J. Bone Miner. Res. pmid:22991192
Luo ZR et al. [A study of relationship between dialectical classification according to traditional Chinese medicine of acute coronary syndrome with serum osteoprotegerin and its ligand]. 2013 Zhonghua Wei Zhong Bing Ji Jiu Yi Xue pmid:24225213
Tisato V et al. GM-CSF exhibits anti-inflammatory activity on endothelial cells derived from chronic venous disease patients. 2013 Mediators Inflamm. pmid:24327798
Aoki A et al. Association of serum osteoprotegerin with vascular calcification in patients with type 2 diabetes. 2013 Cardiovasc Diabetol pmid:23302066
Ambroszkiewicz J et al. Bone turnover markers, osteoprotegerin and RANKL cytokines in children with cystic fibrosis. 2013 Adv Med Sci pmid:24277958
Wong KC et al. Drynaria fortunei-derived total flavonoid fraction and isolated compounds exert oestrogen-like protective effects in bone. 2013 Br. J. Nutr. pmid:23302510
Wada T [RANKL inhibition in bone metastases]. 2013 Nippon Yakurigaku Zasshi pmid:23302944
Shao B et al. [RANKL and OPG expression in bone marrow-derived mesenchymal stem cells of ovariectomied promotes osteoclast development and enhances its function]. 2013 Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi pmid:24321069
Jiang H et al. A randomized controlled trial of pre-conception treatment for periodontal disease to improve periodontal status during pregnancy and birth outcomes. 2013 BMC Pregnancy Childbirth pmid:24321402
Naranjo-Suarez S et al. Regulation of HIF-1α activity by overexpression of thioredoxin is independent of thioredoxin reductase status. 2013 Mol. Cells pmid:23912593
Dorotheou D et al. Tooth eruption: altered gene expression in the dental follicle of patients with cleidocranial dysplasia. 2013 Orthod Craniofac Res pmid:23311656
Zhang J et al. Occlusal effects on longitudinal bone alterations of the temporomandibular joint. 2013 J. Dent. Res. pmid:23340211
Yang B et al. Effect of radiation on the Notch signaling pathway in osteoblasts. 2013 Int. J. Mol. Med. pmid:23340672
Revu S et al. Synovial membrane immunohistology in early-untreated rheumatoid arthritis reveals high expression of catabolic bone markers that is modulated by methotrexate. 2013 Arthritis Res. Ther. pmid:24295447
Kadkhodazadeh M et al. Analysis of RANKL gene polymorphism (rs9533156 and rs2277438) in Iranian patients with chronic periodontitis and periimplantitis. 2013 Arch. Oral Biol. pmid:23177932
Gutiérrez-Rojas I et al. Amylin exerts osteogenic actions with different efficacy depending on the diabetic status. 2013 Mol. Cell. Endocrinol. pmid:23178165
Bolzoni M et al. Immunomodulatory drugs lenalidomide and pomalidomide inhibit multiple myeloma-induced osteoclast formation and the RANKL/OPG ratio in the myeloma microenvironment targeting the expression of adhesion molecules. 2013 Exp. Hematol. pmid:23178378
Lee MH et al. The effect of surface microgrooves and anodic oxidation on the surface characteristics of titanium and the osteogenic activity of human periodontal ligament cells. 2013 Arch. Oral Biol. pmid:22717323
Dalcico R et al. Protective mechanisms of simvastatin in experimental periodontal disease. 2013 J. Periodontol. pmid:23181416
Balani D et al. Interleukin-17A stimulates granulocyte-macrophage colony-stimulating factor release by murine osteoblasts in the presence of 1,25-dihydroxyvitamin D(3) and inhibits murine osteoclast development in vitro. 2013 Arthritis Rheum. pmid:23124514
Osorio A et al. Biochemical markers of vascular calcification in elderly hemodialysis patients. 2013 Mol. Cell. Biochem. pmid:23124853
Kim HS et al. The flavonoid glabridin attenuates 2-deoxy-D-ribose-induced oxidative damage and cellular dysfunction in MC3T3-E1 osteoblastic cells. 2013 Int. J. Mol. Med. pmid:23128413
Ciccone MM et al. Serum osteoprotegerin and carotid intima-media thickness in acute/chronic coronary artery diseases. 2013 J Cardiovasc Med (Hagerstown) pmid:22772598
Scott JP et al. Effect of recovery duration between two bouts of running on bone metabolism. 2013 Med Sci Sports Exerc pmid:23034642

Table of Content